1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6B90850895E3993A000258B3D007AC227
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/SearchNew?OpenForm&Query=(FIELD+Subject+CONTAINS+%22new+product%22+OR+FIELD+Subject+CONTAINS+%22product+develop%22)+AND+(%22new+product%22+or+%22product+develop%22)+and+(field+ItemCatalog=BMR)&SearchWV=1&SearchFuzzy=1&sort=relevance&Start=1&Count=10%22
18
19OpenForm&Query=(FIELD+Subject+CONTAINS+%22new+product%22+OR+FIELD+Subject+CONTAINS+%22product+develop%22)+AND+(%22new+product%22+or+%22product+develop%22)+and+(field+ItemCatalog=BMR)&SearchWV=1&SearchFuzzy=1&sort=relevance&Start=1&Count=10%22
2044.221.66.130
21
22
23best-in-class.com
24/bestp/domrep.nsf
25BMR




Search Results

Results 1 - 10 of 14 Total Hits, Sorted by Relevance.

    |    

Managing Market Planning for New Oncology ProductsDirect access to this research is not included with your membership level.

Understand how leading pharmaceutical companies effectively manage market planning for oncology products during Phase II and Phase III... (ID PSM-205)

$628.00

Pharmaceutical New Product Planning Excellence: Structure & Activities that Drive Profitability & GrowthDirect access to this research is not included with your membership level.

Bio-pharmaceutical organizations are under intense pressure to deliver innovative new products in shorter time frames while minimizing development costs... (ID PSM-333)
Companies Profiled: Alkermes, Allergan, Astellas, Bayer, more ...

Best Practices in Global Branding for New Products: Creating an Effective Global Brand for New Products and Ensuring Alignment across Geographies and AffiliatesDirect access to this research is not included with your membership level.

As the global biopharmaceutical marketplace continues to evolve rapidly, it is important for brand teams to develop an effective global branding program to drive product success... (ID PSM-331)
Companies Profiled: Alkermes, Allergopharma, Asklepion Pharmaceuticals, LLC, more ...

Pharmaceutical New Product Commercialization: Preparing for Market SuccessDirect access to this research is not included with your membership level.

Long and costly product development cycles make it essential for pharmaceutical companies to maximize limited staff and resources to the development ... (ID SM-176)
Companies Profiled: Abbott, Allergan, Alexion Pharmaceuticals, Altus Biologics, more ...

Innovation in Combo Product Clinical Development – Harnessing Patient Insights from Reported Usability OutcomesDirect access to this research is not included with your membership level.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

As the healthcare industry gravitates toward increased patient centricity in an all-out effort to achieve the best possible health outcomes, it follo... (ID POP-308)
Companies Profiled: Novartis, Windtree Therapeutics, EMD Serono, Merck, more ...

Launching New Biopharma Products in Competitive Markets: Critical Success Factors and Failure PointsDirect access to this research is not included with your membership level.

Today's biopharmaceutical launch paradigm is forking in many directions across treatments and therapeutic areas... (ID PSM-369)
Companies Profiled: Adamas Pharmaceuticals, Alkermes, Allergan, Alnylam Pharmaceuticals, more ...

Strategic Portfolio Planning for Successful New Product and Drug Platform PositioningDirect access to this research is not included with your membership level.

As indications become more crowded, and the needs and influence of key stakeholders evolve, pharmaceutical and biotech companies need to meticulously... (ID PSM-365)
Companies Profiled: Abbott, AbbVie, Actelion, Adamas Pharmaceuticals, more ...

Benchmarking Meta-Analysis of New-Product Bridge and Fast-Start Patient Assistance ProgramsDirect access to this research is not included with your membership level.

New-product bridge and fast-start programs are part of integrated patient support services that accelerate patient access to therapy or drive adherence to treatments supporting better outcomes... (ID POP-335)
Companies Profiled: Abbott, AbbVie, Actelion, Adamas Pharmaceuticals, more ...

Driving Growth through New Product Planning and Strategic AlliancesDirect access to this research is not included with your membership level.

Drive overall growth through a well-managed portfolio by addressing current and long-term needs in your company's new product planning and strategic alliance systems... (ID SM-135)
Companies Profiled: Amgen, Eli Lilly, Janssen, Pfizer

Pharmaceutical New Product Planning: Role and Activities for Medical AffairsDirect access to this research is not included with your membership level.

Leading pharmaceutical and biotech companies are increasingly under pressure to deliver effective new products in shorter time frames while minimizing development costs... (ID PSM-249)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, Actelion, Alcon, more ...